AbCellera Biologics Inc. (ABCL) Free cash flow 2019–2025
AbCellera Biologics Inc. (ABCL) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$174.1MFY2025 · since FY2019: -$1.3M → -$174.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$174.1M | +6.9% |
| FY2024 | -$187.0M | -54.7% |
| FY2023 | -$120.8M | -158.5% |
| FY2022 | $206.7M | +11.1% |
| FY2021 | $186.1M | +1329.9% |
| FY2020 | $13.0M | +1099.0% |
| FY2019 | -$1.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice